JP2024088768A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2024088768A5 JP2024088768A5 JP2024063204A JP2024063204A JP2024088768A5 JP 2024088768 A5 JP2024088768 A5 JP 2024088768A5 JP 2024063204 A JP2024063204 A JP 2024063204A JP 2024063204 A JP2024063204 A JP 2024063204A JP 2024088768 A5 JP2024088768 A5 JP 2024088768A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- cancer
- inhibitors
- alkyl
- gpr55
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962906228P | 2019-09-26 | 2019-09-26 | |
| US62/906,228 | 2019-09-26 | ||
| JP2022519475A JP7475731B2 (ja) | 2019-09-26 | 2020-09-25 | カンナビノイドプロドラッグ化合物 |
| PCT/US2020/052829 WO2021062231A2 (en) | 2019-09-26 | 2020-09-25 | Cannabinoid prodrug compounds |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519475A Division JP7475731B2 (ja) | 2019-09-26 | 2020-09-25 | カンナビノイドプロドラッグ化合物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024088768A JP2024088768A (ja) | 2024-07-02 |
| JP2024088768A5 true JP2024088768A5 (https=) | 2024-10-28 |
Family
ID=75166839
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519475A Active JP7475731B2 (ja) | 2019-09-26 | 2020-09-25 | カンナビノイドプロドラッグ化合物 |
| JP2024063204A Pending JP2024088768A (ja) | 2019-09-26 | 2024-04-10 | カンナビノイドプロドラッグ化合物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022519475A Active JP7475731B2 (ja) | 2019-09-26 | 2020-09-25 | カンナビノイドプロドラッグ化合物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US11980602B2 (https=) |
| EP (1) | EP4034100A4 (https=) |
| JP (2) | JP7475731B2 (https=) |
| CA (1) | CA3152168A1 (https=) |
| WO (1) | WO2021062231A2 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116234812A (zh) * | 2020-11-25 | 2023-06-06 | 成都百裕制药股份有限公司 | 大麻素类化合物的制备方法 |
| CN115315418B (zh) * | 2021-04-06 | 2023-03-21 | 山东绿叶制药有限公司 | 大麻二酚前药及其药物组合物和应用 |
| CN116253671B (zh) * | 2021-12-10 | 2025-07-04 | 德义制药有限公司 | 一种大麻二酚衍生物及其制备方法和应用 |
| WO2023235386A1 (en) * | 2022-05-31 | 2023-12-07 | Trait Biosciences, Inc. | Water-soluble cannabinoid prodrugs compositions and methods of synthesizing the same |
| CN120531715B (zh) * | 2025-05-28 | 2026-03-17 | 中国人民解放军军事科学院军事医学研究院 | 大麻二酚在寡肽转运体抑制剂中的应用 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2008107879A1 (en) | 2007-03-05 | 2008-09-12 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | Novel cannabidiol derivatives and their use as anti-inflammatory agents |
| DK2176208T3 (en) | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| AU2017212651B2 (en) * | 2016-01-29 | 2020-01-23 | University Of Mississippi | Biologically active cannabidiol analogs |
| AU2017250303B2 (en) * | 2016-04-15 | 2019-09-26 | Teewinot Technologies Limited | Biosynthesis of cannabinoid prodrugs |
| WO2018091551A1 (en) * | 2016-11-15 | 2018-05-24 | Full Spectrum Laboratories Ltd | Bio-stable cannabinoid compounds and methods for enhancing their physiological concentration |
| EP3980830A4 (en) | 2019-06-06 | 2023-06-07 | Applied Materials, Inc. | IMAGING SYSTEM AND METHOD OF GENERATING COMPOSITE IMAGES |
-
2020
- 2020-09-25 JP JP2022519475A patent/JP7475731B2/ja active Active
- 2020-09-25 CA CA3152168A patent/CA3152168A1/en active Pending
- 2020-09-25 EP EP20867541.3A patent/EP4034100A4/en active Pending
- 2020-09-25 WO PCT/US2020/052829 patent/WO2021062231A2/en not_active Ceased
-
2022
- 2022-03-24 US US17/703,068 patent/US11980602B2/en active Active
-
2024
- 2024-04-10 JP JP2024063204A patent/JP2024088768A/ja active Pending
- 2024-05-13 US US18/662,582 patent/US20240408046A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024088768A5 (https=) | ||
| TWI843705B (zh) | 結晶及其改良製造方法、以及抗體-藥物結合物之改良製造方法 | |
| JP6207509B2 (ja) | 固形腫瘍を治療するためのｆａｐ活性化プロテアソーム阻害剤 | |
| JP2025041725A5 (https=) | ||
| JPWO2020122034A5 (https=) | ||
| JP2015508074A5 (https=) | ||
| JP2019501206A5 (https=) | ||
| DK2678037T3 (en) | Branched linker for protein pharmaceutical conjugates | |
| JP6987641B2 (ja) | シリコン系薬物複合体及びその使用方法 | |
| JP2017518304A5 (https=) | ||
| CN108863963B (zh) | 作为pd-l1抑制剂的杂环类化合物 | |
| ES2755101T3 (es) | Nuevos compuestos y conjugados de criptoficina, su preparación y su uso terapéutico | |
| JPWO2020259258A5 (https=) | ||
| JP2006265245A5 (https=) | ||
| JP2018507197A5 (https=) | ||
| CN116457344A (zh) | 低分子量蛋白质降解剂及其应用 | |
| RU2016130933A (ru) | Сульфонамид-содержащие связывающие системы для лекарственных конъюгатов | |
| RU2007135167A (ru) | Комбинированная терапия с использованием анти-ctla4-антитела и индолинона для лечения рака | |
| JP2018537975A5 (https=) | ||
| JP2004529963A5 (https=) | ||
| JP2016514103A5 (ja) | 細胞結合剤及び細胞毒性剤としてのマイタンシノイドを含む複合体 | |
| JPWO2020027100A5 (https=) | ||
| JPWO2019140301A5 (https=) | ||
| US20170095525A1 (en) | Conjugates and prodrugs for treating of cancer and inflammatory diseases | |
| CN113816990A (zh) | 修饰的氨基酸及其在adc中的应用 |